JCR Pharmaceutical Co, Ltd.
JCR - Model IZCARGO -Lysosomal Disease Product
Therapeutic product for Mucopolysaccharidosis type II. Agalsidase Beta BS I.V. Infusion [JCR]. Therapeutic product for Fabry disease.
Therapeutic product for Mucopolysaccharidosis type II. Agalsidase Beta BS I.V. Infusion [JCR]. Therapeutic product for Fabry disease.